Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..

Plasmodium vivax is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute greatly to control malaria. Recently, using bacterial and adenoviral recombinant proteins based on the P. vivax circumsporozoite protein (CSP),...

Descrición completa

Detalles Bibliográficos
Main Authors: Gimenez, A, Lima, L, Françoso, K, Denapoli, P, Panatieri, R, Bargieri, D, Thiberge, J, Andolina, C, Nosten, F, Renia, L, Nussenzweig, R, Nussenzweig, V, Amino, R, Rodrigues, M, Soares, I
Formato: Journal article
Idioma:English
Publicado: Frontiers Media 2017

Títulos similares